Transcend Capital Advisors, LLC Ishares Biotechnology ETF Transaction History

Transcend Capital Advisors, LLC

$1.29 Billion
Q2 2025

A detailed history of Transcend Capital Advisors, LLC transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 10,321 shares of IBB stock, worth $1.36 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

10,321

Previous 10,985 6.04%

Holding current value

$1.36 Million

Previous $1.4 Million 7.05%

% of portfolio

0.1%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	SELL	$112.02 - $129.0 $74,381 - $85,656	-664 Reduced 6.04%	10,321 $1.31 Million
Q1 2025 Apr 24, 2025	BUY	$127.9 - $140.56 $3,453 - $3,795	27 Added 0.25%	10,985 $1.4 Million
Q4 2024 Feb 03, 2025	BUY	$131.21 - $148.85 $12,071 - $13,694	92 Added 0.85%	10,958 $1.45 Million
Q3 2024 Oct 15, 2024	SELL	$135.09 - $149.47 $5,538 - $6,128	-41 Reduced 0.38%	10,866 $1.58 Million
Q2 2024 Jul 02, 2024	SELL	$124.64 - $139.96 $10,345 - $11,616	-83 Reduced 0.76%	10,907 $1.5 Million
Q1 2024 May 03, 2024	BUY	$132.3 - $140.89 $1,984 - $2,113	15 Added 0.14%	10,990 $1.51 Million
Q4 2023 Feb 05, 2024	BUY	$112.41 - $137.03 $55,867 - $68,103	497 Added 4.74%	10,975 $1.49 Million
Q3 2023 Oct 31, 2023	BUY	$122.27 - $131.47 $48,908 - $52,588	400 Added 3.97%	10,478 $1.28 Million
Q2 2023 Jul 13, 2023	BUY	$125.53 - $133.58 $732,969 - $779,973	5,839 Added 137.74%	10,078 $1.28 Million
Q1 2023 Apr 12, 2023	SELL	$121.97 - $137.23 $195,761 - $220,254	-1,605 Reduced 27.46%	4,239 $547,000
Q4 2022 Jan 20, 2023	BUY	$117.58 - $138.43 $48,090 - $56,617	409 Added 7.53%	5,844 $0
Q3 2022 Oct 17, 2022	BUY	$113.42 - $134.82 $127,484 - $151,537	1,124 Added 26.07%	5,435 $636,000
Q2 2022 Jul 12, 2022	SELL	$105.82 - $134.76 $646,983 - $823,922	-6,114 Reduced 58.65%	4,311 $507,000
Q1 2022 Apr 20, 2022	SELL	$119.6 - $152.37 $1,196 - $1,523	-10 Reduced 0.1%	10,425 $1.36 Million
Q4 2021 Jan 20, 2022	BUY	$145.27 - $164.78 $5,229 - $5,932	36 Added 0.35%	10,435 $1.59 Million
Q3 2021 Nov 04, 2021	SELL	$158.89 - $176.21 $63,714 - $70,660	-401 Reduced 3.71%	10,399 $1.66 Million
Q2 2021 Aug 13, 2021	BUY	$146.13 - $163.65 $453,441 - $507,805	3,103 Added 40.31%	10,800 $1.76 Million
Q1 2021 May 12, 2021	SELL	$146.68 - $172.6 $33,883 - $39,870	-231 Reduced 2.91%	7,697 $1.16 Million
Q4 2020 Feb 12, 2021	SELL	$130.38 - $157.31 $93,612 - $112,948	-718 Reduced 8.3%	7,928 $1.2 Million
Q3 2020 Nov 13, 2020	BUY	$126.88 - $145.8 $1.1 Million - $1.26 Million	8,646 New	8,646 $1.17 Million
Q2 2020 Aug 05, 2020	SELL	$103.79 - $138.65 $338,147 - $451,721	-3,258 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$94.39 - $123.48 $307,522 - $402,297	3,258 New	3,258 $351,000

Others Institutions Holding IBB

# of Institutions

944

Shares Held

30.9M

Call Options Held

4.79M

Put Options Held

5.91M

View Full List

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

More about IBB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Ishares Biotechnology ETF Transaction History